NCEL
NCEL
NASDAQ · Biotechnology

Newcelx Ltd

Penny Stocks Biotech Stocks Healthcare Stocks
$3.36
-0.07 (-2.04%)
As of May 16, 2:30 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +1,107.4% upside
Low Target $36.99
Average Target $40.57
High Target $64.99
Current Price $3.36
Current
$3.36
Target
$40.57
$36.99 $40.57 avg $64.99
Scenario Analysis
Bear Case
$36.99
1,000.9%
Low target
Base Case
$40.57
+1,107.4%
Avg target
Bull Case
$64.99
+1,834.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$30.80
-89.1% from high
52-Week Low
$1.83
+83.6% from low
Target vs 52W High
$40.57
+31.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%